Cardiovascular Health Investigation and Collaboration From Countries of America to Assess the Markers and Outcomes of Chagas Disease (CHICAMOCHA-3) - EQUITY (Equivalence of Usual Interventions for Trypanosomiasis)
Phase of Trial: Phase II/III
Latest Information Update: 25 Jul 2017
At a glance
- Drugs Nifurtimox (Primary) ; Benznidazole
- Indications Chagas disease
- Focus Therapeutic Use
- Acronyms CHICAMOCHA-3; EQUITY
- 18 Jul 2017 Planned End Date changed from 1 Feb 2017 to 1 Feb 2019.
- 18 Jul 2017 Planned primary completion date changed from 1 Feb 2017 to 1 Aug 2018.
- 27 Nov 2015 According to ClinicalTrials.gov record, the treatment table has been amended.